Uncategorized - October 7, 2021
AlzeCure drug candidate is based on a 2021 Nobel discovery
AlzeCure Pharma is developing a novel clinical drug candidate for peripheral neuropathic pain, which is based on the seminal discoveries of TRPV1 by Professor Julius, and for which he is awarded the Nobel Prize in Medicine 2021. David Julius has together with Ardem Patapoutian recently been awarded the 2021 Nobel Prize in Physiology or Medicine. […]
Uncategorized - October 6, 2021
SALSS 2021 – A beloved tradition is back
The Swedish-American Life Science Summit (SALSS) 2021 is on and will take place in Stockholm, Sweden, on October 20-22. The focus on the event will be cell and gene therapy and a crucial discussion on the worldwide pandemic. It will also include exciting company presentations, a rising star exhibit, the announcement of the SALSS Rising […]
Uncategorized - October 6, 2021
The Nobel Prize in Chemistry awards the development of organocatalysis
The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List and David W.C. MacMillan, for the development of a precise new tool for molecular construction. Organocatalysis has had a great impact on pharmaceutical research, and has also made chemistry greener. A third type of catalysis Catalysts […]
Uncategorized - October 5, 2021
The Nobel Prize – Editor’s Pick
Since 2008 Nordic Life Science has dedicated one of our issues every year to the Nobel Prize. These issues have included exclusive interviews with the Laureates, in-depth articles about the discoveries and their applications within life sciences, as well as Nordic progress in the different Nobel-awarded areas. Throughout the years, we have had the opportunity […]
Uncategorized - September 7, 2021
Human-derived mini-brain close to completion
Researchers at the University of Helsinki are growing a human-derived mini-brain from stem cells, containing all of the most important cell types of the human brain. The mini-brain can be used to design personalized therapies for brain diseases. The project has received more than €600,000 support from Business Finland. The new Living Human Brain The […]
Uncategorized - September 7, 2021
15 biomarkers for diseases predisposing to dementia identified
Scientists have identified 15 novel biomarkers that are linked to late-onset dementias. These biomarkers are proteins, which predict cognitive decline and subsequent increased risk of dementia already 20 years before the disease onset. The proteins are related to immune system dysfunction, blood-brain-barrier dysfunction, vascular pathologies, and central insulin resistance. Six of these proteins can be […]